ArticleContemporary clinical trials2025

Development of a pharmacodynamic biomarker of opioid antagonism in adolescents with eating disorders: Study protocol for the naltrexone neuroimaging randomized controlled trial (NN-RCT).

Stephani L Stancil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.